Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07728123 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Screen2Prevent (S2P)

Study acronym: S2P
StatusRecruiting
PhaseNot applicable
SponsorWestat
Started
View on ClinicalTrials.gov ↗

Record History

  1. Site details revised at 3 of 5 sitesv2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Westat
6 trials monitored
See 1 trial at risk
Screen2Prevent is a study intended to improve HIV prevention and detection through implementation and evaluation of three different broad-scale HIV screening approaches a) targeted, b) universally offered opt-in, and c) universally offered opt-out in Emergency Departments (EDs) by leveraging digital health to identify and link adolescents seeking care in the ED to HIV Pre-Exposure Prophylaxis (PrEP)/Antiretroviral treatment (ART).
Trial Details
NCT Number NCT07728123
Lead Sponsor Westat
Conditions HIV Infections
Enrollment 84,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov